Narikazu Boku
- Pulmonary and Respiratory Medicine top 0.05%
- Oncology top 0.1%
- Surgery top 0.2%
- Gastroenterology top 0.05%
- Molecular Biology top 5%
- Co-authors
- Atsushi OhtsuShigeaki YoshidaManabu MutoKuniaki ShiraoKei MuroShuichi HironakaIchinosuke HyodoKensei Yamaguchi
- Topics
- Gastric Cancer Management and Outcomes (315 papers)Colorectal Cancer Treatments and Studies (209 papers)Gastrointestinal Tumor Research and Treatment (99 papers)
- Partner nations
- JapanUnited StatesSouth Korea
In The Last Decade
Narikazu Boku
507 papers receiving 15.0k citations
Hit Papers
Peers
Comparison fields: 5 of 125
- Pulmonary and Respiratory Medicine 10.0k
- Oncology 8.1k
- Surgery 6.3k
- Gastroenterology 3.1k
- Molecular Biology 1.8k
Countries citing papers authored by Narikazu Boku
This map shows the geographic impact of Narikazu Boku's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Narikazu Boku with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Narikazu Boku more than expected).
Fields of papers citing papers by Narikazu Boku
This network shows the impact of papers produced by Narikazu Boku. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Narikazu Boku. The network helps show where Narikazu Boku may publish in the future.
Co-authorship network of co-authors of Narikazu Boku
This figure shows the co-authorship network connecting the top 25 collaborators of Narikazu Boku. A scholar is included among the top collaborators of Narikazu Boku based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Narikazu Boku. Narikazu Boku is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 3 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 2 | |
| 6 | 1 | |
| 7 | 1 | |
| 8 | 11 | |
| 9 | 12 | |
| 10 | 10 | |
| 11 | 61 | |
| 12 | 0 | |
| 13 | 2 | |
| 14 | 7 | |
| 15 | 11 | |
| 16 | 3 | |
| 17 | 30 | |
| 18 | 54 | |
| 19 | Phase I study of sunitinib plus modified FOLFOX6 in Japanese patients with treatment-naive colorectal cancer. | 6 |
| 20 | 39 |
About Narikazu Boku
Narikazu Boku is a scholar working on Gastroenterology, Oncology and Pulmonary and Respiratory Medicine, having authored 541 papers that have together received 15.3k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (315 papers), Colorectal Cancer Treatments and Studies (209 papers) and Gastrointestinal Tumor Research and Treatment (99 papers). The work is most often cited by research in Gastroenterology (3.1k citations), Pulmonary and Respiratory Medicine (10.0k citations) and Oncology (8.1k citations). Narikazu Boku has collaborated with scholars based in Japan, United States and South Korea. Frequent co-authors include Atsushi Ohtsu, Shigeaki Yoshida, Manabu Muto, Kuniaki Shirao, Kei Muro, Shuichi Hironaka, Ichinosuke Hyodo, Kensei Yamaguchi, Haruhiko Fukuda and Hiroshi Saito. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.